June 5-7, 2024

WI3R Symposium 2024


The organizing committee is happy to welcome you to the 1st International Conference of the Würzburg Initiative 3R (WI3R)! The event is organized by the Fraunhofer TLC-RT, supported by the German Research Foundation (DFG) funded research clusters SFB/TRR 225 ("From the fundamentals of biofabrication towards functional tissue models"), GRK2157 (3D-Infect), SFB 1583 (Decide) and the Chair Tissue Engineering & Regenerative Medicine (TERM) of University Hospital (UKW) and University of Würzburg, respectively as a joint event. The Fraunhofer TLC-RT as well as TERM (UKW) develop new cell based tissue models and test systems, scalable manufacture processes, prototypes and biological vascularized implants, therefore contributing to the 3R principles. The SFB/TRR 225 Collaborative Research Centre is interested in exploring the fundamentals of biofabrication and its systematic exploitation with the aim to generate functional human tissue models. This holds the possibility of automated production of functional tissue models that would be invaluable as animal test replacements, for research on new drug compounds and cancer therapy, and as option for regenerative therapy. The GRK2157 and SFB 1583 networks focus on the development of human 3D tissue models for infection research aiming to identify molecular mechanisms within the host that control the course of infectious diseases. For more information please visit the respective webpages.

Within this 1st WI3R symposium the German Research Foundation (DFG) will grant the 20th anniversary of the Ursula M. Händel Animal Welfare Prize. The Ursula M. Händel Prize recognises scientists who have made exemplary and sustained efforts to improve the welfare of animals in research. In particular, this includes the development of methods that contribute to the reduction, refinement and replacement of animal experiments. The €80,000 Ursula M. Händel Animal Welfare Prize is currently the largest prize of its kind in Germany, awarded every two years.

Please find more information about the objectives of the event, the speakers and the preliminary program on this webpage.

You will also be able to explore the content and see the list of invited speakers. You can also register and submit an abstract directly through this webpage

Objectives of the WI3R Symposium

  1. Biofabrication and 3D printing
  2. human iPSC and organoids
  3. Emerging technologies
  4. New approach methods (NAMs)
  5. Disease modeling (infection, oncology)
  6. Regulatory acceptance
  7. Promotion of young investigators (Special non-PI meeting, 3x travel grants available, please check the registration and submission form)
  8. DFG Ursula M. Händel Animal Welfare Prize ceremony

Looking forward to see you in Würzburg soon!

Please find the Abstract book and final program here:

Confirmed speakers...

  • Prof. Winfried Neuhaus

    Prof. Winfried Neuhaus

    AIT - Austrian Institute of Technology GmbH, Center Health and Bioresources, Competence Unit Molecular Diagnostics, Vienna (Austria) & Danube Private University, Faculty of Medicine and Dentistry, Department of Medicine, Krems (Austria)

  • Dr. Jennifer Rosowski

    Dr. Jennifer Rosowski

    Charité - Universitätsmedizin Berlin Campus Virchow-Klinikum, Coordination Charite 3R, Berlin (Germany)

  • Dr. Michael Oelgeschläger

    Dr. Michael Oelgeschläger

    German Federal Institute for Risk Assessment, Unit Strategies for Toxicological Assessments, Berlin (Germany)

  • Prof. Ulrich Dirnagl

    Prof. Ulrich Dirnagl

    QUEST Center for Transforming Biomedical Research, Berlin Institute of Health, Berlin (Germany)

  • Dr. Valentin Wegner

    Dr. Valentin Wegner

    Institute of Biochemistry II, Center for Sepsis Control and Care, Research Group INSPIRE, Jena University Hospital, Jena (Germany)

  • PD Dr. Henner Farin

    PD Dr. Henner Farin

    Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt (Germany)

  • Prof. Matthias P. Lütolf

    Prof. Matthias P. Lütolf

    Institute of Human Biology, Bioengineering/Multi-Tissue Systems Engineering, Swiss Federal Institute of Technology (EPFL), Lausanne (Switzerland)

  • Dr. Woojung Shin

    Dr. Woojung Shin

    Department of Bio and Brain Engineering Korea Advanced Institute of Science and Technology (KAIST), Daejeon (South Korea)

  • Dr. Julia Schüler

    Dr. Julia Schüler

    Therapeutic Area Lead Oncology at Charles River Discovery Research Services Germany GmbH, Freiburg (Germany)

  • Dr. Katharina Koch

    Dr. Katharina Koch

    Head of Research and Development at DNTOX GmbH and Postdoctoral Researcher at Leibniz Research Institute for Environmental Medicine, Düsseldorf (Germany)

  • Prof. Giovanni Vozzi

    Prof. Giovanni Vozzi

    Interdepartmental Research Center "E. Piaggio", Faculty of Engineering, University of Pisa (Italy)

  • Dr. Larry Schlesinger

    Dr. Larry Schlesinger

    Texas Biomedical Research Institute, San Antonio (USA)

  • Prof. Rene H. Tolba

    Prof. Rene H. Tolba

    RWTH Aachen University, Institute for Laboratory Animal Science & Experimental Surgery and Central Laboratory for Laboratory Animal Science, Aachen (Germany)

  • Dr. Marian Raschke

    Dr. Marian Raschke

    Bayer AG, Research & Development, Pharmaceuticals Advanced Cellular Models, Berlin (Germany)

  • Dr. Dilyana Filipova

    Dr. Dilyana Filipova

    Doctors Against Animal Experiments, Cologne (Germany)

  • Dr. Katrin Mestermann

    Dr. Katrin Mestermann

    Department of Internal Medicine II, University Hospital Würzburg (Germany)


  • DFG


  • Bundesnetzwerk 3R


Rudolf Virchow Center

2, Haus D15, Josef-Schneider-Str. 2, Haus D15 Würzburg , Bavaria Germany , D-97080

Contact us

If you have any questions, please contact oezlem.elbert@isc.fraunhofer.de .

Powered by